JHU37152,98.75%
产品编号:Bellancom-131891| CAS NO:2369979-67-7| 分子式:C19H20ClFN4| 分子量:358.84
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
JHU37152
产品介绍 | JHU37152 是一种有效和可透过血脑屏障的 DREADD 激动剂,对 hM3Dq 和 hM4Di DREADDs 的 EC50 值分别为 5 nM 和 0.5 nM。JHU37152 在小鼠脑组织中表现出来自 DREADDs 的选择性 [3H]Clozapine 置换作用,而不来自其他 Clozapine 结合部位。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | JHU37152 is a potent and brain-penetrant DREADD agonist, with EC50s of 5 nM and 0.5 nM for hM3Dq and hM4Di DREADDs in HEK-293 cells, respectively. JHU37152 exhibits selective [3H]Clozapine displacement from DREADDs and not from other Clozapine-binding sites in mice brain tissue. | ||||||||||||||||
体外研究 |
JHU37152 displays high DREADD affinity, with Kis of 1.8 nM and 8.7 nM for hM3Dq and hM4Di expressed in mouse brain sections. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
JHU37152 (0.1 mg/kg; i.p.) exhibits high DREADD occupancy in mice and rats. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
JHU37152 (0.1 mg/kg; i.p.) exhibits high DREADD occupancy in mice and rats. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 33.33 mg/mL (92.88 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
参考文献 |